机构:[1]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China[2]Kunming Med Univ, Dept Thorac Surg, Affiliated Hosp 3, Kunming 650118, Yunnan, Peoples R China[3]Kunming Med Univ, Dept Geriatr, Affiliated Hosp 1, Kunming 650032, Yunnan, Peoples R China昆明医科大学附属第一医院
The host immune system plays a crucial role in multiple types of cancer, including non-small-cell lung cancer (NSCLC). Transporter associated with antigen processing (TAP) protein heterodimer complexes might promote intracellular antigen peptide binding with class I major histocompatibility complex (MHC-I) molecules, and in recent years, TAP1 and TAP2 have been reported to be associated with multiple cancer risks. In the current study, we investigated the association of single-nucleotide polymorphisms (SNPs) in TAP1 and TAP2 with NSCLC in a Han Chinese population. Six and seven TAP1 and TAP2 SNPs, respectively, were genotyped and analysed in healthy controls and NSCLC patients. Based on our data, none of the six SNPs in TAP1 is associated with NSCLC risk (P > 0.0038). However, rs2228396 alleles in TAP2 were significantly different between NSCLC patients and healthy controls, and the A allele might be associated with an increased risk of this cancer (P = 0.001, OR = 1.65, 95%CI: 1.23 similar to 2.21). Moreover, the genotype frequencies of rs2228396 were significantly different between patients and healthy con-trols (P = 7 x 10(-4)). Additionally, TAP2 rs241441 alleles exhibited a trend of difference between NSCLC patients and healthy controls, with the C allele possibly being associated with increased risk of NSCLC (P = 0.013; OR = 1.30, 95%CI: 1.06 similar to 1.60). Moreover, the genotypes of rs241441 in TAP2 showed a signif-icant difference between NSCLC patients and healthy controls (P = 1 x 10(-4)). In haplotype analysis, the TAP2 SNP haplotype (CAC, TAP2*0102) was significantly associated with increased NSCLC risk in the Han Chinese population (P = 0.003; OR = 1.57, 95%CI: 1.17 similar to 2.10). Our results indicate that TAP2 SNPs (rs2228396 and rs241441) have a potential role in NSCLC pathogenesis. (C) 2021 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
基金:
Fundamental Research Funds for the Central Universities and the PUMC Youth
Fund (3332021071), the Special Funds for High-level Healthy
Talents of Yunnan Province (L-201615 and H-2018014) and the
Association Foundation Program of the Yunnan Provincial Science,
Technology Department and Kunming Medical University (No.
2018FE001-219).
第一作者机构:[1]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China[*1]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Dept Immunogenet, Kunming 650118, Yunnan, Peoples R China[*2]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming 650118, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
Liu Weipeng,Ma Qianli,Li Chuanyin,et al.The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population[J].HUMAN IMMUNOLOGY.2021,82(12):917-922.doi:10.1016/j.humimm.2021.07.014.
APA:
Liu, Weipeng,Ma, Qianli,Li, Chuanyin,Li, Yingfu,Liu, Shuyuan...&Yao, Yufeng.(2021).The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.HUMAN IMMUNOLOGY,82,(12)
MLA:
Liu, Weipeng,et al."The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population".HUMAN IMMUNOLOGY 82..12(2021):917-922